Showing results (421-430 of 445) with videos related to
Sort By:
Pageof 45
Heart (British Cardiac Society)|November 3, 2012
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trialRoberto Diletti, Vasim Farooq, Chrysafios Girasis, et al.JACC. Cardiovascular Interventions|December 24, 2011
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trialSalvatore Brugaletta, Josep Gomez-Lara, Patrick W Serruys, et al.JAMA Health Forum|October 31, 2025
Manifestations of Structural Racism and Inequities in Cardiovascular Health Across US NeighborhoodsWayne R Lawrence, Hyokyoung G Hong, Faustine Williams, et al.Nature Genetics|February 2, 2000
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumoursE A Rapley, G P Crockford, D Teare, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2S R Lakhani, B A Gusterson, J Jacquemier, et al.Neuro-Oncology|January 19, 2013
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcomeShadi Lalezari, Arthur P Chou, Anh Tran, et al.British Journal of Cancer|May 20, 2004
Somatic mutations of KIT in familial testicular germ cell tumoursE A Rapley, S Hockley, W Warren, et al.Human Molecular Genetics|January 13, 2006
Genome-wide linkage screen for testicular germ cell tumour susceptibility lociGillian P Crockford, Rachel Linger, Sarah Hockley, et al.Journal of the National Cancer Institute|August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsS R Lakhani, J Jacquemier, J P Sloane, et al.American Journal of Human Genetics|December 29, 2005
The Y deletion gr/gr and susceptibility to testicular germ cell tumorKatherine L Nathanson, Peter A Kanetsky, Rachel Hawes, et al.Pageof 45